defect
interf
particl
dip
caus
critic
absenc
part
viral
genom
unabl
replic
need
standard
viru
known
helper
viru
complet
viru
coinfect
research
discov
inact
virus
could
stop
spread
influenza
virus
henl
henl
later
von
magnu
discov
interfer
viral
replic
caus
incomplet
form
influenza
viru
incomplet
form
prolifer
presenc
standard
virus
von
magnu
incomplet
form
virus
renam
dip
defect
interf
particl
viral
origin
structur
featur
homolog
standard
virus
typic
delet
form
viral
genom
call
defect
interf
di
genom
huang
baltimor
di
genom
truncat
form
viral
genom
gener
virus
viral
replic
found
di
genom
retain
termin
sequenc
recogn
viral
polymeras
sequenc
packag
compet
initi
site
complementari
sequenc
end
structur
sequenc
requir
encapsul
nucleocapsid
resend
et
al
mura
et
al
gener
di
genom
often
refer
copychoic
mechan
caus
viral
polymeras
polymeras
skip
one
templat
anoth
one
part
templat
part
resum
elong
end
nascent
chain
synthes
skip
lazzarini
et
al
perrault
differ
type
di
genom
kolakofski
leppert
et
al
list
simpl
intern
delet
di
genom
delet
gener
fragment
templat
skip
perrault
jaworski
routh
copyback
panhandl
di
genom
fodor
et
al
polymeras
carri
partial
made
strand
switch
back
transcrib
end
form
panhandl
shape
hairpin
snapback
di
genom
replicas
transcrib
part
one
strand
use
new
strand
templat
result
format
hairpin
schubert
lazzarini
mosaic
complex
di
genom
variou
region
may
come
helper
viru
genom
wrong
order
differ
helper
genom
segment
could
includ
segment
host
rna
mura
et
al
mutat
di
genom
novel
di
genom
type
deriv
influenza
virus
report
genom
viral
rna
segment
encod
protein
genom
packag
signal
carri
point
mutat
affect
promot
region
kupk
et
al
absenc
mutat
critic
part
viral
genom
dip
selfrepl
white
morri
infect
cell
interfer
replic
genet
compat
virus
coinfect
standard
viru
standard
viru
help
facilit
replic
packag
di
genom
transcomplement
lead
releas
mainli
noninfecti
dip
differ
type
di
genom
depict
figur
defect
interf
particl
observ
infect
major
dna
rna
virus
herp
simplex
viru
hsv
harti
et
al
pseudorabi
viru
wu
et
al
geminiviru
ageratum
yellow
vein
viru
ayvv
stanley
et
al
dna
virus
plant
huang
patil
dasgupta
polioviru
lundquist
et
al
measl
cattaneo
et
al
pfaller
et
al
sindbi
viru
kennedi
et
al
petterson
et
al
vesicular
stomat
viru
vsv
giachetti
holland
influenza
viru
fazeka
graham
kupk
et
al
dengu
viru
li
aaskov
sar
coronaviru
raman
brian
west
nile
viru
brinton
produc
dip
phage
also
abl
gener
dip
serial
passag
bacteriophag
high
multipl
infect
result
appear
defect
delet
mutant
miniphag
interfer
growth
wildtyp
horiuchi
mani
year
past
numer
studi
reveal
dip
exert
antiviru
effect
differ
type
dip
interfer
viral
replic
reproduct
divers
mechan
area
current
novel
research
hotspot
howev
research
point
dip
caus
persist
infect
viru
remov
complet
develop
gene
sequenc
recombin
recent
year
dip
attract
interest
research
di
genom
probe
increas
secur
dip
meanwhil
dip
construct
use
antivir
vaccin
also
reveal
dip
antitumor
effect
liu
et
al
review
interfer
mechan
dip
effect
tumor
summar
upon
investig
dip
expect
becom
new
class
antivir
antitumor
agent
clinic
implic
critic
part
innat
immun
type
ifn
thought
respons
antivir
effect
dipsdi
genom
deriv
studi
show
evid
link
dip
type
ifn
frens
et
al
defect
influenza
viru
rna
serv
protect
mice
simultan
challeng
lethal
dose
influenza
awsn
viru
protect
subtyp
influenza
viru
observ
indic
type
ifn
might
play
role
protect
due
presenc
strong
antigen
defect
rna
virion
transmiss
prefer
pack
noninfecti
defect
virion
nearbi
cell
also
part
mechan
dimmock
et
al
similar
result
observ
sendai
viru
di
genom
doublestrand
rna
potenti
trigger
increas
express
type
ifn
strahl
et
al
three
pathway
contribut
induct
type
ifn
effort
made
illustr
underli
mechan
pathway
doublestrand
rna
base
length
appear
major
dipsdi
genom
import
induc
type
ifn
cell
marcu
gaccion
strahl
et
al
retino
acidinduc
gene
rigi
serv
pivot
detector
intracellular
rna
recogn
dipsdi
genom
particular
structur
sanchez
et
al
vasou
et
al
cytoplasm
di
genom
rather
fulllength
viru
genom
sendai
viru
preferenti
bound
rig
exert
immunostimulatori
activ
influenzainfect
cell
rigi
intracellular
rna
detector
preferenti
bound
shorter
genom
includ
di
genom
immunostimulatori
activ
test
confirm
downstream
signal
rigi
induc
express
type
ifn
baum
et
al
studi
also
suggest
rigi
role
induct
type
ifn
di
rna
especi
copyback
form
type
pathogen
associ
molecular
pattern
pamp
stemloop
structur
ideal
ligand
rigi
strong
induc
type
interferon
ifn
yoshida
et
al
rigi
recognit
rna
effect
augment
product
ifn
goubau
et
al
di
rna
contain
intermediatelength
doublestrand
region
found
measl
viru
perfect
agonist
rigi
quantit
realtim
rtpcr
result
reveal
immunostimulatori
activ
character
increas
express
type
ifn
also
signific
subsequ
induct
adapt
immun
ho
et
al
thu
sens
cytoplasm
rna
rigi
trigger
deliv
downstream
signal
interact
helicas
adaptor
protein
promot
stimul
result
innat
immun
respons
mediat
type
ifn
mogensen
previous
consid
neg
modul
bind
dipsdi
genom
upregul
type
ifn
express
belong
cytoplasm
pattern
recognit
receptor
rigi
absenc
domain
requir
trigger
ifn
signal
cascad
via
mitochondri
antivir
signal
mav
activ
di
genom
recombin
measl
viru
strong
induc
type
ifn
h
infect
vitro
addit
comparison
bind
efficaci
infect
viru
di
genom
indic
measl
viru
di
rna
appear
enrich
highlight
crucial
role
type
ifn
mediat
respons
mura
et
al
melanoma
differentiationassoci
protein
associ
type
ifn
regul
yount
et
al
tapia
et
al
sun
et
al
posit
modul
cytoplasm
differ
rigi
distinct
recognit
pattern
studi
show
measl
di
particl
could
agonist
though
fraction
magnitud
low
rel
rung
et
al
mura
et
al
could
attribut
short
structur
measl
viru
di
particl
deep
sequenc
approach
may
need
elucid
connect
di
particl
upon
activ
induc
ifn
express
similar
rigi
activ
exert
antivir
respons
activ
rigi
lead
upregul
type
ifn
chang
immun
environ
howev
characterist
differ
structur
dipsdi
genom
known
associ
differ
pathway
exampl
copyback
di
genom
effici
bind
rigi
genom
length
anoth
aspect
affect
bind
di
genom
short
doublestrand
detect
rigi
wherea
long
doublestrand
rna
without
phosphat
prefer
bound
last
least
rna
di
particl
especi
rich
u
residu
contribut
rigi
activ
howev
littl
known
singlestrand
di
genom
stimul
type
ifn
express
relat
host
cellular
pathway
antivir
outcom
type
ifn
remain
unclear
therefor
attent
paid
elucid
regul
cellular
pathway
viral
infect
di
genom
viru
produc
variou
type
genom
differ
pathway
may
result
differ
effect
addit
influenc
secondari
structur
viral
rna
activ
also
open
worth
investig
viral
rna
vari
highli
address
problem
could
shed
light
techniqu
improv
come
obtain
optim
dipsdi
genom
gene
modif
recent
studi
involv
anim
model
achiev
advanc
dipsdi
genom
show
protect
homolog
viru
also
heterolog
viru
studi
scott
et
al
demonstr
dip
influenza
viru
type
show
heterolog
protect
influenza
viru
type
b
dip
stimul
product
type
ifn
protect
effect
dip
influenza
viru
type
b
reduc
knock
type
ifn
receptor
gene
mice
suggest
product
type
ifn
signific
indic
type
ifn
involv
alter
antivir
environ
immun
cell
modul
immun
system
might
gener
addit
heterolog
protect
effect
furthermor
influenza
b
virus
interact
replic
scott
et
al
howev
intranas
administr
dip
influenza
viru
type
help
fight
pneumonia
virus
besid
influenza
b
virus
mice
easton
et
al
underli
mechan
heterolog
protect
unknown
could
hypothes
type
ifn
play
role
increas
activ
natur
killer
cell
type
ifn
broadspectrum
antivir
protein
effect
immun
modul
adapt
immun
could
anoth
potenti
factor
elimin
heterolog
viru
immun
cell
function
link
innat
immun
adapt
immun
greatli
enhanc
type
ifn
mellman
steinman
therefor
induct
type
ifn
upon
strong
stimul
dipsdi
genom
activ
immun
system
heterolog
protect
sendai
respiratori
syncyti
viru
infect
defect
viral
genom
facilit
viral
persist
promot
mechan
stimul
mavsmedi
tnf
respons
xu
et
al
thu
mechan
employ
dip
influenc
innat
immun
remain
uncertain
oppos
function
dip
common
virus
defect
particlesgenom
trigger
matur
dendrit
cell
dc
vivo
enhanc
antigenspecif
immun
virus
host
cell
mercadolopez
et
al
frens
et
al
mechan
clearli
understood
worth
investig
peripher
antigen
present
cell
includ
dc
may
high
probabl
contact
prefer
pack
dipsdi
genom
strongli
antigen
noninfecti
type
ifn
induct
improv
abil
dc
effici
bind
agonist
process
antigen
well
upregul
cytokin
link
innat
immun
adapt
immun
addit
specul
product
antibodi
exert
antivir
activ
express
type
ii
ifn
also
known
follow
dc
matur
involv
induc
specif
antivir
cell
vivo
mercadolopez
et
al
dendrit
cell
matur
essenti
activ
adapt
immun
respons
maintain
longlast
protect
reinfect
viru
dip
sendai
viru
provid
higher
titer
dcactiv
viru
replic
intermedi
product
probabl
dsrna
recogn
pathogenassoci
stimuli
trigger
tlrindepend
pathway
costimulatori
molecul
chemokin
chemokin
receptor
numer
proinflammatori
cytokin
mellman
steinman
yount
et
al
interestingli
dc
matur
abil
di
particl
improv
demonstr
di
particl
ad
viru
weakli
activ
dc
could
hypothes
increas
level
antigenom
promot
copyback
dip
viral
composit
exist
cell
membran
endosom
compart
could
trigger
dc
matur
gene
thu
initi
type
ifn
signalingdepend
independ
dc
matur
thu
effect
dipsinduc
dc
matur
involv
antivir
mechan
could
ration
design
viral
vaccin
outstand
antivir
effect
wasik
et
al
dip
expect
use
vaccin
adjuv
stimul
adapt
immun
respons
studi
report
dip
influenza
viru
type
di
viru
could
protect
ferret
mustela
putoriu
furo
dimmock
et
al
infect
complet
influenza
viru
particl
allevi
symptom
vaccin
mix
intact
influenza
viru
dip
induc
high
titer
hemagglutinininhibit
antibodi
ferret
intact
influenza
viru
could
detect
day
vaccin
moreov
viru
could
also
detect
day
suggest
high
titer
hemagglutinin
inhibitori
antibodi
also
kill
dip
evid
confirm
dipsdi
genom
involv
antibodi
induct
cell
activ
viru
exert
antiinfluenza
viru
effect
human
respiratori
cell
smith
et
al
simultan
vaccin
herp
viru
type
recombin
hsv
type
glycoprotein
induc
high
titer
neutral
antibodi
hsvspecif
cell
respons
dudek
knipe
mention
activ
adapt
immun
inhibit
heterolog
virus
express
similar
structur
antigen
standard
viru
therefor
dip
highli
promis
candid
vaccin
develop
properti
dipsdi
genom
noninfecti
decent
antigen
attract
attent
research
later
util
gene
recombin
technolog
modifi
dip
safe
vaccin
adenovir
vector
induc
longlast
effect
cell
respons
hepat
c
viru
thought
novel
vaccin
viru
wen
et
al
dimmock
easton
rhesu
monkey
treat
dip
replicationdefect
hepat
c
viru
adenoviru
recombin
dip
cellular
immun
effect
antibodi
respons
multipl
virus
induc
rhesu
monkey
studi
provid
rational
develop
antivir
vaccin
clinic
trial
addit
found
dip
mump
viru
could
allevi
neurotox
wildtyp
mump
viru
provid
basi
new
mump
vaccin
santak
et
al
research
construct
two
adenovir
interf
particl
replicationrel
gene
delet
express
surfac
highli
recombin
fusion
protein
hemagglutinin
inject
mice
dip
induc
antibodi
product
along
cell
respons
specif
pest
de
petit
rumin
viru
pprv
antigen
roja
et
al
dipsdi
genom
perfect
candid
vaccin
worth
develop
safe
agent
viru
deep
gene
sequenc
gene
modif
shed
light
prospect
futur
scientist
could
creat
dipsdi
genom
vaccin
without
pathogen
wherea
evalu
confirm
modifi
dipsdi
genom
lead
multipl
frequenc
viru
mutat
mutat
result
advers
outcom
remain
ongo
thu
far
dipsdi
genom
provid
promis
immun
stimulatori
effect
comprehens
preclin
data
avail
dip
influenza
viru
type
dimmock
easton
sendai
viru
yount
et
al
semliki
forest
viru
barrett
dimmock
howev
key
aspect
care
note
although
major
studi
suggest
administr
dipsdi
genom
inhibitori
even
therapeut
effect
standard
viru
notic
replic
process
reduc
abolish
thu
deeper
understand
mechan
need
order
clear
standard
viru
come
clinic
use
addit
persist
influenza
viru
rna
report
cultur
cell
condit
viru
replic
marcu
sekellick
cane
et
al
cane
dimmock
therebi
indic
urgent
need
investig
mechan
elimin
measur
persist
dipsdi
genom
dipsdi
genom
promis
futur
antivir
agent
altern
could
lead
advers
outcom
new
infect
happen
therefor
preclin
trial
requir
support
potenti
use
dip
antivir
agent
multipl
mechan
dip
may
activ
immun
system
depict
figur
dip
attach
cell
unless
surfac
protein
requir
entri
absent
prevent
virus
invad
cell
dip
invad
cell
delet
genom
fragment
affect
interact
virus
receptor
cell
membran
defect
interf
particl
implic
cofactor
reduc
preval
dengu
viru
aaskov
et
al
well
sever
diseas
li
et
al
defect
dengu
viru
type
genom
found
persist
infect
mosquito
cell
infect
aed
albopictu
cell
found
delet
dengu
viru
type
genom
encod
e
protein
block
infecti
viru
adsorpt
penetr
lack
gene
show
inhibit
replic
methyl
juarezmartinez
et
al
howev
specif
mechan
dipsdi
genom
block
complet
viru
adsorpt
penetr
need
explor
whether
phenomenon
exist
dipsdi
genom
virus
also
need
observ
defect
interf
particl
compet
essenti
synthes
helper
viru
host
cell
limit
amount
result
inhibit
replic
standard
viru
dimmock
easton
report
influenza
viru
dip
interf
replic
step
rather
transcript
step
viral
rna
synthesi
nayak
et
al
dip
vsv
whose
rna
genom
encod
five
protein
nucleocapsid
n
protein
encapsul
genom
rna
phosphoprotein
p
larg
l
protein
make
polymeras
glycoprotein
g
involv
cellsurfac
bind
matrix
protein
import
virion
format
inhibit
host
antivir
gene
express
hank
et
al
interf
replic
helper
viru
palma
et
al
delet
form
dip
contain
smaller
genom
helper
viru
di
genom
therefor
replic
faster
standard
genom
polymeras
synthes
copi
di
genom
certain
period
comparison
standard
genom
di
genom
predomin
sever
round
replic
number
di
genom
easili
exceed
helper
genom
even
ratio
di
helper
initi
low
marriott
dimmock
dip
recogn
molecular
parasit
due
exist
high
amount
di
genom
neg
factor
sequest
di
genom
viral
polymeras
compon
host
protein
roux
et
al
exampl
studi
shown
di
standard
genom
compet
solubl
extract
contain
viral
l
p
protein
ie
compon
viral
rnadepend
rna
polymeras
dip
influenza
viru
type
compet
polymeras
helper
viru
dip
produc
larg
number
enzym
resourc
would
exhaust
ultim
caus
inhibit
helper
viru
lask
et
al
di
rna
also
interfer
replic
davi
nayak
li
et
al
determin
di
dengu
viral
particl
replic
manner
full
length
genom
replic
di
fulllength
genom
need
structur
region
viral
genom
di
genom
lack
region
genom
rna
encod
protein
complet
depend
wild
type
virus
make
deficit
consequ
compet
function
genom
viral
host
cell
protein
addit
defect
delet
mutant
bacteriophag
also
interfer
growth
replic
wildtyp
horiuchi
sever
studi
shown
dipsgenom
exert
antivir
effect
affect
packag
step
besid
rna
synthesi
step
standard
viru
particl
virus
virion
contain
gene
di
rna
select
deplet
fulllength
gene
complet
influenza
viru
reveal
use
northern
blot
analysi
studi
convincingli
show
express
gene
infect
cell
dramat
reduc
amount
parent
segment
releas
viru
greatli
diminish
illustr
competit
effect
packag
duhaut
mccauley
dengu
viral
dip
influenza
viral
dip
whose
genom
contain
delet
could
also
affect
process
packag
besid
rna
synthesi
viral
polymeras
duhaut
mccauley
li
aaskov
abund
smaller
di
genom
like
packag
new
viru
particl
faster
rate
packag
standard
viru
genom
liao
et
al
found
clone
influenza
di
rna
play
interfer
role
replac
cognat
fulllength
rna
progeni
virion
therefor
clone
influenza
di
rna
preferenti
packag
meng
et
al
mutat
form
dip
also
abl
affect
packag
process
unknown
novel
dip
influenza
viru
type
viru
contain
numer
point
mutat
instead
larg
delet
defin
research
use
singlecel
analysi
gener
natur
genet
substitut
due
point
mutat
viru
observ
reduc
hemagglutin
assay
ha
titer
human
cell
line
coinfect
standard
viru
besid
sever
reduct
infect
releas
virion
promisingli
protect
subtyp
influenza
viru
type
madindarbi
canin
kidney
mdck
cell
pandem
influenza
viru
subtyp
subtyp
influenza
viru
ahong
report
interfer
could
account
advanc
genom
replic
importantli
preferenti
packag
dip
found
particular
type
dip
produc
excess
higher
quantiti
vrna
intracellularli
releas
viru
particl
play
role
promot
region
encod
protein
genom
packag
signal
consid
noninfecti
thu
infect
influenza
viru
partial
suppress
experi
kupk
et
al
cellular
endosom
sort
complex
requir
transport
escrt
compos
cytosol
protein
complex
accessori
protein
escrt
complex
enabl
uniqu
mode
membran
remodel
allow
membran
bend
bud
away
cytoplasm
carlton
martinserrano
babst
schmidt
tei
releas
viral
particl
also
call
viral
bud
releas
virion
cell
via
hijack
host
cell
escrt
machineri
jouvenet
et
al
vottel
sundquist
found
dip
produc
lymphocyt
choriomening
viru
inhibit
releas
homolog
virus
promot
dip
releas
modifi
escrt
pathway
therebi
exert
antivir
effect
ziegler
et
al
virus
mention
report
advers
affect
releas
step
standard
viru
although
numer
studi
indic
dip
suppress
differ
stage
viru
replic
cycl
still
lack
data
dynam
intracellular
behavior
multipl
mechan
dip
may
suppress
viru
replic
cycl
depict
figur
summar
differ
mechan
dip
interfer
viru
replic
see
tabl
defect
interf
particlesdefect
interf
genom
induc
cellselect
apoptosi
cancer
rigi
downstream
signal
horiuchi
ho
et
al
mura
et
al
rigi
preferenti
recogn
short
rna
sequenc
bp
kb
triphosphor
ppp
end
kato
et
al
hwang
et
al
thought
one
rna
sens
pattern
recognit
receptor
prr
prr
anoth
critic
costimulatori
molecul
immun
cell
notabl
myeloid
cell
macrophag
dc
takeuchi
akira
prr
agonist
abl
activ
phagocytosi
antigen
present
myeloid
cell
resid
tumor
microenviron
preclin
trial
prr
agonist
also
directli
induc
immunogen
cell
death
particular
type
apoptosi
trigger
immun
respons
specif
dead
cellassoci
antigen
shekarian
et
al
new
way
use
dipsdi
genom
prr
agonist
exert
antitumor
effect
research
suggest
certain
sendai
viru
dip
contain
short
rna
genom
nucleotid
strongli
induc
rigidepend
apoptosi
copyback
type
dip
exist
cantel
strain
hvj
effect
activ
proapoptot
gene
cancer
cell
induc
apoptot
effect
strain
cantel
strain
contain
fewer
di
particl
xenograft
mous
model
intratumor
transduct
di
particlederiv
rna
synthes
vitro
transcript
vitro
transcrib
ivt
significantli
reduc
size
human
prostat
cancer
doublestrand
region
secondari
structur
trigger
rigi
downstream
signal
associ
activ
apoptot
gene
includ
noxa
andor
tnfrelat
apoptosisinduc
ligand
trail
increas
ifn
product
activ
proapoptot
gene
cancer
cell
liu
et
al
thu
prr
agonist
di
genom
analog
reagent
induc
rigrel
anticanc
effect
along
therapeut
drug
abl
enhanc
antitumor
effect
immun
system
consequ
cancer
cell
growth
could
suppress
cancer
cell
suscept
rigi
induc
apoptosi
wu
et
al
studi
underli
mechan
activ
rigidepend
apoptosi
cancer
cell
like
due
bind
dip
rna
rna
sens
prr
viral
infect
lead
activ
signal
protein
tumor
necrosi
factor
receptorassoci
factor
traf
serin
kinas
kinas
lead
activ
master
transcript
factor
interferon
regulatori
factor
nfkb
signal
howev
research
data
propos
antitumor
effect
dipsdi
genom
indepth
studi
need
address
relat
differ
cancer
cell
dipsdi
genom
studi
mention
copyback
type
dip
play
antitumor
role
activ
rigi
downstream
signal
pathway
howev
need
explor
whether
dip
type
inhibit
tumor
cell
mechan
employ
antitumor
effect
experi
mice
dip
sendai
viru
exert
antitumor
effect
activ
antitumor
immun
induc
dc
cell
experi
indic
mice
administr
dip
tumor
growth
inhibit
tumor
volum
significantli
reduc
shi
et
al
liu
et
al
experiment
mice
matur
dc
observ
tumor
tissu
along
increas
releas
cytokin
well
express
level
mrna
flow
cytometri
analysi
show
express
marker
dc
matur
includ
dosedepend
increas
dip
thu
antitumor
effect
dip
relat
activ
dc
cellinduc
immun
studi
use
mice
sever
combin
immunodefici
suggest
natur
killer
nk
cell
also
involv
anticanc
effect
induc
administr
rna
activ
nk
cell
might
attract
tumor
via
chemoattract
might
enhanc
nk
cell
activ
tumor
microenviron
liu
et
al
thu
dc
display
antigen
tumor
cell
exert
antitumor
effect
matur
dc
express
costimul
factor
essenti
activ
immun
cell
tumor
kill
effect
takeuchi
akira
mechan
dip
exert
antitumor
effect
depict
figur
rapid
develop
genom
sequenc
help
research
design
di
genom
therapi
virus
tumor
antivir
antitumor
effect
safeti
evalu
dip
still
preclin
trial
stage
mani
difficulti
overcom
instanc
dip
may
lead
drug
resist
standard
virus
tradit
antivir
drug
could
caus
spread
virus
divers
defect
fragment
dip
sever
affect
product
efficaci
dose
dip
requir
treatment
difficult
determin
moreov
dip
may
show
differ
effect
vitro
vivo
current
genom
sequenc
technolog
beauclair
et
al
dip
produc
genom
sequenc
natur
occur
dip
indic
possibl
clinic
applic
product
far
mani
studi
confirm
dip
interfer
reproduct
virus
review
provid
comprehens
summari
differ
mechan
dip
may
exert
antivir
effect
experiment
studi
report
antitumor
abil
dip
could
use
vaccin
nowaday
although
variou
therapi
explor
treat
cancer
includ
surgeri
chemotherapi
radiotherapi
immunotherapi
treatment
may
induc
sever
side
effect
andor
drug
resist
dip
redeem
possibl
effici
way
elimin
cancer
cell
minim
side
effect
scientist
built
experiment
comput
framework
detect
dipsassoci
delet
influenza
b
viru
use
deep
genom
sequenc
approach
precis
mechan
underli
regul
dipsdi
genom
alnaji
et
al
report
show
possibl
gener
pure
product
dipsdi
genom
absenc
standard
viru
vitro
bdeir
et
al
yamagata
et
al
techniqu
shed
light
develop
dipsdi
genom
improv
safeti
use
advanc
gene
sequenc
genet
recombin
technolog
modifi
dip
construct
exert
antivir
antitumor
effect
addit
compar
spontan
deriv
dip
side
effect
continu
infect
viru
significantli
reduc
modifi
dip
indepth
research
dip
expect
becom
new
class
antivir
antitumor
agent
clinic
implic
wz
bz
qw
cs
lz
involv
concept
write
manuscript
yy
tl
rz
xh
wrote
manuscript
ky
tc
qx
prepar
figur
tabl
wz
bz
check
manuscript
author
read
approv
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
